pubmed-article:1537076 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1537076 | lifeskim:mentions | umls-concept:C0178539 | lld:lifeskim |
pubmed-article:1537076 | lifeskim:mentions | umls-concept:C0008163 | lld:lifeskim |
pubmed-article:1537076 | lifeskim:mentions | umls-concept:C0032949 | lld:lifeskim |
pubmed-article:1537076 | lifeskim:mentions | umls-concept:C0032950 | lld:lifeskim |
pubmed-article:1537076 | lifeskim:mentions | umls-concept:C0022702 | lld:lifeskim |
pubmed-article:1537076 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
pubmed-article:1537076 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:1537076 | pubmed:dateCreated | 1992-3-30 | lld:pubmed |
pubmed-article:1537076 | pubmed:abstractText | Intracellular concentrations of prednimustine (PM), chlorambucil (CLB), phenylacetic acid mustard (PAAM) and prednisolone (P) were measured in different experimental tumor cell lines that had been incubated with either PM or CLB + P. For intracellular analytical determination, we modified a high-pressure liquid chromatographic method for the detection of these substances in plasma. Intact PM could be detected in the intracellular compartment of the incubated tumor cells. PM-incubated cells from PM-injected rats exhibited a higher intracellular concentration-time integral (PAAM) and longer concentration-time profiles for drugs with alkylating capacity than did cells exposed to the CLB + P mixture or to CLB. PAAM was not detectable after incubation of cells with PM, whereas in CLB-incubated cells the AUC of PAAM exceeded that of the parent drug CLB. Our in vitro results therefore favour the concept of a facilitated intracellular uptake and an increased antiproliferative effect for PM versus CLB and CLB + P. | lld:pubmed |
pubmed-article:1537076 | pubmed:language | eng | lld:pubmed |
pubmed-article:1537076 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1537076 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1537076 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1537076 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1537076 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1537076 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1537076 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1537076 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1537076 | pubmed:issn | 0344-5704 | lld:pubmed |
pubmed-article:1537076 | pubmed:author | pubmed-author:RiedelEE | lld:pubmed |
pubmed-article:1537076 | pubmed:author | pubmed-author:RinkHH | lld:pubmed |
pubmed-article:1537076 | pubmed:author | pubmed-author:EggsFF | lld:pubmed |
pubmed-article:1537076 | pubmed:author | pubmed-author:LathamAA | lld:pubmed |
pubmed-article:1537076 | pubmed:author | pubmed-author:MalecEE | lld:pubmed |
pubmed-article:1537076 | pubmed:author | pubmed-author:MuschEE | lld:pubmed |
pubmed-article:1537076 | pubmed:author | pubmed-author:Peter-Katalin... | lld:pubmed |
pubmed-article:1537076 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1537076 | pubmed:volume | 29 | lld:pubmed |
pubmed-article:1537076 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1537076 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1537076 | pubmed:pagination | 297-304 | lld:pubmed |
pubmed-article:1537076 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:1537076 | pubmed:meshHeading | pubmed-meshheading:1537076-... | lld:pubmed |
pubmed-article:1537076 | pubmed:meshHeading | pubmed-meshheading:1537076-... | lld:pubmed |
pubmed-article:1537076 | pubmed:meshHeading | pubmed-meshheading:1537076-... | lld:pubmed |
pubmed-article:1537076 | pubmed:meshHeading | pubmed-meshheading:1537076-... | lld:pubmed |
pubmed-article:1537076 | pubmed:meshHeading | pubmed-meshheading:1537076-... | lld:pubmed |
pubmed-article:1537076 | pubmed:meshHeading | pubmed-meshheading:1537076-... | lld:pubmed |
pubmed-article:1537076 | pubmed:meshHeading | pubmed-meshheading:1537076-... | lld:pubmed |
pubmed-article:1537076 | pubmed:meshHeading | pubmed-meshheading:1537076-... | lld:pubmed |
pubmed-article:1537076 | pubmed:meshHeading | pubmed-meshheading:1537076-... | lld:pubmed |
pubmed-article:1537076 | pubmed:meshHeading | pubmed-meshheading:1537076-... | lld:pubmed |
pubmed-article:1537076 | pubmed:meshHeading | pubmed-meshheading:1537076-... | lld:pubmed |
pubmed-article:1537076 | pubmed:meshHeading | pubmed-meshheading:1537076-... | lld:pubmed |
pubmed-article:1537076 | pubmed:meshHeading | pubmed-meshheading:1537076-... | lld:pubmed |
pubmed-article:1537076 | pubmed:meshHeading | pubmed-meshheading:1537076-... | lld:pubmed |
pubmed-article:1537076 | pubmed:year | 1992 | lld:pubmed |
pubmed-article:1537076 | pubmed:articleTitle | Cellular kinetics of prednimustine versus chlorambucil plus prednisolone in vitro. | lld:pubmed |
pubmed-article:1537076 | pubmed:affiliation | Department of Internal Medicine, Mary's Hospital Bottrop, FRG. | lld:pubmed |
pubmed-article:1537076 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:1537076 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:1537076 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |